The LATAM CRO Queen

In this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with Sara Tylosky, CEO at Farmacon Global. Your host, Raman Sehgal, discusses the pharmaceutical and biotechnology supply chain with Sara, covering: The gift and curse of being known for rescuing complex clinical trials The data challenge of rare diseases and how that impacts patient access Navigating the complexity of rare diseases in Latin America and why it all starts with education How her father's role in building space stations globally inspired her own international business journey The future of clinical trials and why Latin America is well positioned to be a leading player Sara brings over 20 years of experience leading teams in both large and small pharmaceutical and biotech environments. She has led Farmacon Global, a strategic CRO of medical consultants, in accelerating clinical trials, increasing diversity, supporting enrollment, and paving the way to market access in emerging markets. Known for her high cultural intelligence and problem-solving skills, Sara and her team specialize in Rare Diseases, Immunology, Infectious Diseases, Cancer, and Vaccines. Fluent in Spanish and having lived on four continents, she has a special focus on Latin America while actively expanding into other key markets globally. Sara's direction plays a pivotal role in steering Farmacon Global toward healthcare innovation and global market leadership. Please subscribe, tell your industry colleagues and join us in celebrating and promoting the value and importance of the global life science outsourcing space. We’d also appreciate a positive rating! Molecule to Market is also sponsored and funded by ramarketing, an international marketing, design, digital and content agency helping companies differentiate, get noticed and grow in life sciences.